PharMerica

New Study Published in Journal of American Medical Directors Association Highlights the BrightSpring Health Services CCRx Program for Medication Management, Including Superior Study Outcomes and a 73% Reduction in Hospitalization Rate Achieved

Retrieved on: 
Tuesday, November 21, 2023

Researchers hypothesized that home health patients utilizing the CCRx program may have lower hospitalization rates.

Key Points: 
  • Researchers hypothesized that home health patients utilizing the CCRx program may have lower hospitalization rates.
  • Between May 1, 2021, and March 31, 2023, 113 home health patients whose insurance covered the program were enrolled in CCRx.
  • Home health patients ineligible for the program due to a non-covered pharmacy insurance benefit made up the control group (n=21,304).
  • The successful CCRx study is another example of the very positive quality results achieved through our services and by combining BrightSpring’s home health care and medication management solutions for a better outcome.”

FRUZAQLA™ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)

Retrieved on: 
Tuesday, November 21, 2023

Fruzaqla™ is a selective oral inhibitor of VEGFR-1, VEGFR-2, and VEGFR-3, which play a pivotal role in blocking tumor angiogenesis.

Key Points: 
  • Fruzaqla™ is a selective oral inhibitor of VEGFR-1, VEGFR-2, and VEGFR-3, which play a pivotal role in blocking tumor angiogenesis.
  • Colorectal cancer is the fourth most frequent diagnosed cancer and second leading cause of death in the U.S.
  • Fruquintinib vs Placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicenter, randomized double blind, phase 3 study.
  • Effect of fruquintinib vs Placebo on overall survival in patients with previously treated metastatic colorectal cancer.

AKEEGA™ (niraparib and abiraterone acetate) Now Available from Onco360

Retrieved on: 
Tuesday, October 3, 2023

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by The Janssen Pharmaceutical Companies of Johnson & Johnson for AKEEGA™ (niraparib and abiraterone acetate).

Key Points: 
  • Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by The Janssen Pharmaceutical Companies of Johnson & Johnson for AKEEGA™ (niraparib and abiraterone acetate).
  • Patients should be selected for therapy based on an FDA-approved test for AKEEGA.
  • Patients taking AKEEGA should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had a bilateral orchiectomy.
  • “Onco360 is thankful for the opportunity to partner with the team at Janssen and become a specialty pharmacy provider for AKEEGA,” said Benito Fernandez, Chief Commercial Officer.

CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation

Retrieved on: 
Friday, September 15, 2023

PHILADELPHIA, PA, Sept 15, 2023 - (ACN Newswire) - Amid technological advances in the credentialing industry and a growing global focus on addressing health workforce deployment, CGFNS International announced today it has appointed a new Chief Technology Officer.

Key Points: 
  • PHILADELPHIA, PA, Sept 15, 2023 - (ACN Newswire) - Amid technological advances in the credentialing industry and a growing global focus on addressing health workforce deployment, CGFNS International announced today it has appointed a new Chief Technology Officer.
  • Nish Jayamohan comes to CGFNS with nearly two decades of experience managing technology product and application development in the healthcare space.
  • Nish Jayamohan - Chief Technology Officer, CGFNS International
    As CTO, Jayamohan will lead the organization's efforts to transform its technology platforms and processes with the goal of enhancing and streamlining customer experience, expanding its programs and building a new framework for credentials evaluation and verification and workforce development on a global scale.
  • He previously served as a senior technical lead developing and managing software for Health Net, a large healthcare insurance provider.

Amerita Notifies Individuals of Privacy Incident

Retrieved on: 
Tuesday, September 5, 2023

Amerita announced today that it is notifying individuals who may have been affected by an incident involving some of their personal information.

Key Points: 
  • Amerita announced today that it is notifying individuals who may have been affected by an incident involving some of their personal information.
  • Upon discovering the incident, Amerita promptly began an internal investigation and engaged cybersecurity experts to investigate and secure its computer systems.
  • Amerita recently identified a data set involved in the incident that contained the personal information of some Amerita patients.
  • Amerita has no indication that the incident involved Amerita patients’ Social Security numbers or driver’s license numbers.

Three Gardant Management Solutions Communities Achieve 2023 AHCA/NCAL Silver National Quality Award

Retrieved on: 
Friday, June 30, 2023

BOURBONNAIS, Ill., June 30, 2023 /PRNewswire-PRWeb/ -- Three Gardant-managed affordable assisted living communities were among eight assisted living communities nationally to be named recipients of a 2023 Silver Achievement in Quality Award from the American Health Care Association/National Center for Assisted Living.

Key Points: 
  • Three Gardant-managed affordable assisted living communities were among eight assisted living communities nationally to be named recipients of a 2023 Silver Achievement in Quality Award from the American Health Care Association/National Center for Assisted Living.
  • BOURBONNAIS, Ill., June 30, 2023 /PRNewswire-PRWeb/ -- Three Gardant-managed affordable assisted living communities were among eight assisted living communities nationally to be named recipients of a 2023 Silver Achievement in Quality Award from the American Health Care Association/National Center for Assisted Living.
  • "We are extremely proud of these Gardant-managed communities for being named recipients of a 2023 Silver Award," says Alexandra Shuell, Vice President of Operations for Gardant Management Solutions, Inc. "The award recognizes communities that have reached a standard of excellence in quality based on the Baldrige Excellence Framework."
  • The 2023 National Quality Award program is sponsored by AHCA/NCAL Associate Business Members PharMerica, Pinnacle Quality Insight, Prevail by First Quality, HealthCap, and Matrix Care.

Silver Golub & Teitell LLP Investigates PharMerica Class Action Lawsuit Data Breach Claims

Retrieved on: 
Thursday, June 22, 2023

STAMFORD, Conn., June 22, 2023 /PRNewswire/ -- Silver Golub & Teitell LLP ("SGT"), a plaintiffs' class action law firm which represents data breach victims, continues to investigate potential class action data breach claims against PharMerica Corporation ("PharMerica") following a data breach that exposed the sensitive personal information and health information of almost 6 million PharMerica pharmacy customers (the "Data Breach").

Key Points: 
  • STAMFORD, Conn., June 22, 2023 /PRNewswire/ -- Silver Golub & Teitell LLP ("SGT"), a plaintiffs' class action law firm which represents data breach victims, continues to investigate potential class action data breach claims against PharMerica Corporation ("PharMerica") following a data breach that exposed the sensitive personal information and health information of almost 6 million PharMerica pharmacy customers (the "Data Breach").
  • PharMerica has sent notification letters to individuals impacted by the data breach by US Mail.
  • If you have received a notification letter and would like to learn more about your options, reach out to SGT today
    A class action lawsuit has been filed in federal court as a result of the PharMerica Data Breach and SGT is continuing to investigate claims against PharMerica.
  • According to media reports and PharMerica itself, the following information of impacted individuals has been compromised as a result of the Data Breach

Console & Associates, P.C.: Over Five Million Patient Social Security Numbers SSNs Leaked in PharMerica Data Breach

Retrieved on: 
Tuesday, May 30, 2023

In the company's data breach letter, PharMerica offers affected patients 12 months of credit monitoring and identity protection services through Experian IdentityWorks.

Key Points: 
  • In the company's data breach letter, PharMerica offers affected patients 12 months of credit monitoring and identity protection services through Experian IdentityWorks.
  • Patients who receive a data breach notification letter from PharMerica should enroll in this service immediately.
  • What should you do if you receive a PharMerica data breach letter?
  • Anyone who has received a Notice of Data Breach letter from PharMerica may contact the firm to learn more about their rights.

Emerson Firm PLLC Announces Investigation of PharMerica Data Breach

Retrieved on: 
Tuesday, May 16, 2023

HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Emerson Firm, PLLC (“Emerson”) announces a continuing investigation of the data breach at PharMerica Corporation (“PM”).

Key Points: 
  • HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Emerson Firm, PLLC (“Emerson”) announces a continuing investigation of the data breach at PharMerica Corporation (“PM”).
  • This investigation relates to the theft of sensitive personal identifiable information (“PII”) of 5,815,591 million customers.
  • PM recently started delivering data breach notification letters on May 12, 2023, to individuals affected by the recent data security incident.
  • Emerson with offices in Houston, TX is a law firm specializing in results, integrity, and personal service.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By the PharMerica Data Breach

Retrieved on: 
Tuesday, May 16, 2023

NEWTOWN, Pa., May 16, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by PharMerica Corporation (“PharMerica” or the “Company”) resulting from a data breach that occurred between March 12 and March 13, 2023.

Key Points: 
  • NEWTOWN, Pa., May 16, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by PharMerica Corporation (“PharMerica” or the “Company”) resulting from a data breach that occurred between March 12 and March 13, 2023.
  • The Company learned of suspicious activity on March 14, 2023, but failed to notify customers until May 12, 2023.
  • On March 14, 2023, the Company was alerted about a potential data breach.
  • Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the PharMerica data breach.